Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Health Res Policy Syst ; 18(1): 88, 2020 Aug 08.
Article in English | MEDLINE | ID: mdl-32771004

ABSTRACT

The opioid epidemic in the United States has had a devastating impact on millions of people as well as on their families and communities. The increased prevalence of opioid misuse, use disorder and overdose in recent years has highlighted the need for improved public health approaches for reducing the tremendous harms of this illness. In this paper, we explain and call for the need for more systems science approaches, which can uncover the complexities of the opioid crisis, and help evaluate, analyse and forecast the effectiveness of ongoing and new policy interventions. Similar to how a stream of systems science research helped policy development in infectious diseases and obesity, more systems science research is needed in opioids.


Subject(s)
Drug Overdose , Epidemics , Opioid-Related Disorders , Analgesics, Opioid , Drug Overdose/drug therapy , Drug Overdose/epidemiology , Humans , Opioid Epidemic , Opioid-Related Disorders/drug therapy , Opioid-Related Disorders/epidemiology , United States
2.
Health Res Policy Syst ; 18(1): 87, 2020 Aug 06.
Article in English | MEDLINE | ID: mdl-32762700

ABSTRACT

The prevalence of opioid use and misuse has provoked a staggering number of deaths over the past two and a half decades. Much attention has focused on individual risks according to various characteristics and experiences. However, broader social and contextual domains are also essential contributors to the opioid crisis such as interpersonal relationships and the conditions of the community and society that people live in. Despite efforts to tackle the issue, the rates of opioid misuse and non-fatal and fatal overdose remain high. Many call for a broad public health approach, but articulation of what such a strategy could entail has not been fully realised. In order to improve the awareness surrounding opioid misuse, we developed a social-ecological framework that helps conceptualise the multivariable risk factors of opioid misuse and facilitates reviewing them in individual, interpersonal, communal and societal levels. Our framework illustrates the multi-layer complexity of the opioid crisis that more completely captures the crisis as a multidimensional issue requiring a broader and integrated approach to prevention and treatment.


Subject(s)
Drug Overdose , Opioid-Related Disorders , Analgesics, Opioid , Drug Overdose/drug therapy , Drug Overdose/epidemiology , Humans , Opioid Epidemic , Opioid-Related Disorders/drug therapy , Opioid-Related Disorders/epidemiology , Public Health
5.
Subst Abus ; 33(4): 321-6, 2012.
Article in English | MEDLINE | ID: mdl-22989275

ABSTRACT

Professional guidelines recommend annual screening, brief intervention, and referral to treatment (SBIRT) as part of health maintenance for all adolescents, but reported screening rates have been low and no report has documented the techniques being used. The objective of this study was to describe the results of a statewide questionnaire regarding adolescent substance use screening rates and techniques used by primary care physicians practicing in Massachusetts. A questionnaire was mailed to every licensed physician registered as practicing pediatrics (N = 2176), family medicine (N = 1335), or both (N = 8) in the Massachusetts Board of Medicine database. After eliminating physicians who did not provide care for adolescents, the survey response rate was 28% and the final analyzable sample consisted of 743 surveys. Less than half of respondents reported using a validated adolescent screening tool. The majority of respondents used ineffective screening practices for adolescent substance use. Further physician training is recommended to encourage the use of developmentally appropriate screening tools and interventions for adolescents.


Subject(s)
Adolescent Health Services/statistics & numerical data , Data Collection/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Primary Health Care/statistics & numerical data , Substance Abuse Detection/statistics & numerical data , Adolescent , Attitude of Health Personnel , Child , Data Collection/methods , Female , Guideline Adherence/statistics & numerical data , Humans , Male , Massachusetts , Middle Aged , Substance Abuse Detection/methods , Surveys and Questionnaires
7.
Pediatrics ; 147(Suppl 2): S195-S203, 2021 01.
Article in English | MEDLINE | ID: mdl-33386322

ABSTRACT

Despite the disproportionate impact of substance use on young adults, as well as their unique developmental circumstances, there has historically been little attention given to the substance use care needs of this population. As a result, there are currently few evidence-based recommendations to guide clinicians in caring for young adults with substance use disorders. The Grayken Center for Addiction Medicine at Boston Medical Center convened an interdisciplinary meeting of experts to establish principles of care to guide the management of young adults with substance use disorders, to help health care organizations establish effective care systems for these patients, and to help guide policy. In this article, we review the care principles and introduce a series of linked articles that go into further details of principles in the domains of evidence-based substance use treatment, family engagement in care, recovery support services, comorbid psychiatric illness, harm reduction, and criminal justice system reform.


Subject(s)
Consensus , Evidence-Based Medicine , Family , Substance-Related Disorders/therapy , Age Factors , Boston , Criminal Law , Diagnosis, Dual (Psychiatry) , Evidence-Based Medicine/standards , Harm Reduction , Health Services Accessibility , Human Development , Humans , Mental Disorders/therapy , Mental Health Recovery , Patient Acceptance of Health Care , Patient-Centered Care/standards , Standard of Care , Substance-Related Disorders/psychology , Young Adult
8.
Pediatrics ; 147(Suppl 2): S220-S228, 2021 01.
Article in English | MEDLINE | ID: mdl-33386325

ABSTRACT

In summarizing the proceedings of a longitudinal meeting of experts in substance use disorders (SUDs) among young adults, this special article reviews principles of care concerning recovery support services for this population. Young adults in recovery from SUDs can benefit from a variety of support services throughout the process of recovery. These services take place in both traditional clinical settings and settings outside the health system, and they can be delivered by a wide variety of nonprofessional and paraprofessional individuals. In this article, we communicate fundamental points related to guidance, evidence, and clinical considerations about 3 basic principles for recovery support services: (1) given their developmental needs, young adults affected by SUDs should have access to a wide variety of recovery support services regardless of the levels of care they need, which could range from early intervention services to medically managed intensive inpatient services; (2) the workforce for addiction services for young adults benefits from the inclusion of individuals with lived experience in addiction; and (3) recovery support services should be integrated to promote recovery most effectively and provide the strongest possible social support.


Subject(s)
Delivery of Health Care, Integrated , Health Services Accessibility , Patient Care Team/organization & administration , Psychosocial Support Systems , Substance-Related Disorders/therapy , Activities of Daily Living , Consensus Development Conferences as Topic , Episode of Care , Evidence-Based Medicine , Health Resources , Housing , Humans , Interpersonal Relations , Mental Health Recovery , United States , United States Substance Abuse and Mental Health Services Administration , Young Adult
9.
JAMA Psychiatry ; 77(7): 737-744, 2020 07 01.
Article in English | MEDLINE | ID: mdl-32374360

ABSTRACT

Importance: The increase in deaths related to drugs, alcohol, and suicide (referred to as deaths from despair) has been identified as a public health crisis. The antecedents associated with these deaths have, however, seldom been investigated empirically. Objective: To prospectively examine the association between religious service attendance and deaths from despair. Design, Setting, and Participants: This population-based cohort study used data extracted from self-reported questionnaires and medical records of 66 492 female registered nurses who participated in the Nurses' Health Study II (NHSII) from 2001 through 2017 and 43 141 male health care professionals (eg, dentist, pharmacist, optometrist, osteopath, podiatrist, and veterinarian) who participated in the Health Professionals Follow-up Study (HPFS) from 1988 through 2014. Data on causes of death were obtained from death certificates and medical records. Data analysis was conducted from September 2, 2018, to July 14, 2019. Exposure: Religious service attendance was self-reported at study baseline in response to the question, "How often do you go to religious meetings or services?" Main Outcomes and Measures: Deaths from despair, defined specifically as deaths from suicide, unintentional poisoning by alcohol or drug overdose, and chronic liver diseases and cirrhosis. Cox proportional hazards regression models were used to estimate the hazard ratio (HR) of deaths from despair by religious service attendance at study baseline, with adjustment for baseline sociodemographic characteristics, lifestyle factors, psychological distress, medical history, and other aspects of social integration. Results: Among the 66 492 female participants in NHSII (mean [SD] age, 46.33 [4.66] years), 75 incident deaths from despair were identified (during 1 039 465 person-years of follow-up). Among the 43 141 male participants in HPFS (mean [SD] age, 55.12 [9.53] years), there were 306 incident deaths from despair (during 973 736 person-years of follow-up). In the fully adjusted models, compared with those who never attended religious services, participants who attended services at least once per week had a 68% lower hazard (HR, 0.32; 95% CI, 0.16-0.62) of death from despair in NHSII and a 33% lower hazard (HR, 0.67; 95% CI, 0.48-0.94) of death from despair in HPFS. Conclusions and Relevance: The findings suggest that religious service attendance is associated with a lower risk of death from despair among health care professionals. These results may be important in understanding trends in deaths from despair in the general population.


Subject(s)
Alcohol-Related Disorders/mortality , Drug Overdose/mortality , Health Personnel/statistics & numerical data , Religion and Psychology , Suicide, Completed/statistics & numerical data , Adult , Cohort Studies , Female , Humans , Male , Middle Aged , Nurses/statistics & numerical data , Proportional Hazards Models , United States/epidemiology
10.
J Gen Intern Med ; 23(9): 1393-8, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18592319

ABSTRACT

BACKGROUND: Buprenorphine is a safe, effective and underutilized treatment for opioid dependence that requires special credentialing, known as a waiver, to prescribe in the United States. OBJECTIVE: To describe buprenorphine clinical practices and barriers among office-based physicians. DESIGN: Cross-sectional survey. PARTICIPANTS: Two hundred thirty-five office-based physicians waivered to prescribe buprenorphine in Massachusetts. MEASUREMENTS: Questionnaires mailed to all waivered physicians in Massachusetts in October and November 2005 included questions on medical specialty, practice setting, clinical practices, and barriers to prescribing. Logistic regression analyses were used to identify factors associated with prescribing. RESULTS: Prescribers were 66% of respondents and prescribed to a median of ten patients. Clinical practices included mandatory counseling (79%), drug screening (82%), observed induction (57%), linkage to methadone maintenance (40%), and storing buprenorphine notes separate from other medical records (33%). Most non-prescribers (54%) reported they would prescribe if barriers were reduced. Being a primary care physician compared to a psychiatrist (AOR: 3.02; 95% CI: 1.48-6.18) and solo practice only compared to group practice (AOR: 3.01; 95% CI: 1.23-7.35) were associated with prescribing, while reporting low patient demand (AOR: 0.043, 95% CI: 0.009-0.21) and insufficient institutional support (AOR: 0.37; 95% CI: 0.15-0.89) were associated with not prescribing. CONCLUSIONS: Capacity for increased buprenorphine prescribing exists among physicians who have already obtained a waiver to prescribe. Increased efforts to link waivered physicians with opioid-dependent patients and initiatives to improve institutional support may mitigate barriers to buprenorphine treatment. Several guideline-driven practices have been widely adopted, such as adjunctive counseling and monitoring patients with drug screening.


Subject(s)
Buprenorphine/therapeutic use , Narcotic Antagonists/therapeutic use , Opioid-Related Disorders/drug therapy , Practice Patterns, Physicians' , Cross-Sectional Studies , Data Collection , Humans , Massachusetts , Physicians, Family , Private Practice , Psychiatry
11.
Public Health Rep ; 133(1_suppl): 24S-34S, 2018.
Article in English | MEDLINE | ID: mdl-30426871

ABSTRACT

Drug overdose is now the leading cause of injury death in the United States. Most overdose fatalities involve opioids, which include prescription medication, heroin, and illicit fentanyl. Current data reveal that the overdose crisis affects all demographic groups and that overdose rates are now rising most rapidly among African Americans. We provide a public health perspective that can be used to mobilize a comprehensive local, state, and national response to the opioid crisis. We argue that framing the crisis from a public health perspective requires considering the interaction of multiple determinants, including structural factors (eg, poverty and racism), the inadequate management of pain, and poor access to addiction treatment and harm-reduction services (eg, syringe services). We propose a novel ecological framework for harmful opioid use that provides multiple recommendations to improve public health and clinical practice, including improved data collection to guide resource allocation, steps to increase safer prescribing, stigma-reduction campaigns, increased spending on harm reduction and treatment, criminal justice policy reform, and regulatory changes related to controlled substances. Focusing on these opportunities provides the greatest chance of making a measured and sustained impact on overdose and related harms.


Subject(s)
Drug Overdose/prevention & control , Health Policy , Opioid-Related Disorders/prevention & control , Opioid-Related Disorders/therapy , Public Health/methods , Criminal Law/legislation & jurisprudence , Data Collection/methods , Drug Overdose/mortality , Harm Reduction , Health Services Accessibility/organization & administration , Pain Management/methods , Practice Patterns, Physicians'/standards , Public Health/legislation & jurisprudence , Public Health/standards , Research Design , Social Determinants of Health/statistics & numerical data , Social Stigma , Socioeconomic Factors , United States
13.
Arch Intern Med ; 171(5): 425-31, 2011 Mar 14.
Article in English | MEDLINE | ID: mdl-21403039

ABSTRACT

BACKGROUND: Opioid addiction is a chronic disease treatable in primary care settings with buprenorphine hydrochloride, but this treatment remains underused. We describe a collaborative care model for managing opioid addiction with buprenorphine hydrochloride-naloxone hydrochloride dihydrate sublingual tablets. METHODS: Ours is a cohort study of patients treated for opioid addiction using collaborative care between nurse care managers and generalist physicians in an urban academic primary care practice during a 5-year period. We examine patient characteristics, 12-month treatment success (ie, retention or taper after 6 months), and predictors of successful outcomes. RESULTS: From September 1, 2003, through September 30, 2008, 408 patients with opioid addiction were treated with buprenorphine. Twenty-six patients were excluded from analysis because they left treatment owing to preexisting legal or medical conditions or a need to transfer to another buprenorphine program. At 1 year, 196 of 382 patients (51.3%) underwent successful treatment. Of patients remaining in treatment at 12 months, 154 of 169 (91.1%) were no longer using illicit opioids or cocaine based on urine drug test results. On admission, patients who were older, were employed, and used illicit buprenorphine had significantly higher odds of treatment success; those of African American or Hispanic/Latino race had significantly lower odds of treatment success. These outcomes were achieved with a model that facilitated physician involvement. CONCLUSION: Collaborative care with nurse care managers in an urban primary care practice is an alternative and successful treatment method for most patients with opioid addiction that makes effective use of time for physicians who prescribe buprenorphine.


Subject(s)
Behavior, Addictive/drug therapy , Buprenorphine/therapeutic use , Naloxone/therapeutic use , Narcotic Antagonists/therapeutic use , Opioid-Related Disorders/drug therapy , Opioid-Related Disorders/nursing , Adult , Black or African American/statistics & numerical data , Cohort Studies , Drug Users , Female , Hispanic or Latino/statistics & numerical data , Humans , Male , Middle Aged , Primary Health Care , Prospective Studies , Retrospective Studies , Treatment Outcome , White People/statistics & numerical data
14.
J Subst Abuse Treat ; 40(3): 241-54, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21257282

ABSTRACT

Five states (Connecticut, Massachusetts, New York, North Carolina, and Oklahoma) have incorporated the Washington Circle (WC) substance abuse performance measures in various ways into their quality improvement strategies. In this article, we focus on what other states and local providers might learn from these states' experiences as they consider using WC performance measures. Using a case study approach, we report that the use of WC measures differs across these five states, although there are important common themes required for adoption and sustainability of performance measures, which include leadership, evaluation of specification and use of measures over time, state-specific adaptation of the WC measure specifications, collaboration with consultants and partners, inclusion of WC measures in the context of other initiatives, reporting to providers and the public, and data and resource requirements. As additional states adopt some of the WC measures, or adopt other performance measurement approaches, these states' experiences could help them to develop implementations based on their particular needs.


Subject(s)
Quality Assurance, Health Care/methods , Substance Abuse Treatment Centers/standards , Substance-Related Disorders/rehabilitation , Cooperative Behavior , Humans , Public Sector , Quality Indicators, Health Care , United States
SELECTION OF CITATIONS
SEARCH DETAIL